Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 9;74(7):1279-1283.
doi: 10.1093/cid/ciab726.

Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease

Shivakumar Narayanan  1 , Joel V Chua  1 , John W Baddley  1
Affiliations
Review

Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease

Shivakumar Narayanan et al. Clin Infect Dis. .

Abstract

The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian subcontinent in early 2021 was marked by an unusually high number of COVID-19-associated mucormycosis (CAM) cases reported during this same period. This is significantly higher than predicted based on available data about prevalence and risk factors for this condition. This may be due to an unusual alignment of multiple risk factors for this condition. There is high background prevalence of mucormycosis in India likely from a high prevalence of risk factors, including undiagnosed or poorly controlled diabetes. COVID-19-induced immune dysregulation and immune suppression from steroid therapy increase the risk. The role of environmental exposure is unclear. System factors such as lack of access to healthcare during a pandemic may result in delayed diagnosis or suboptimal management with potentially poor outcomes. Here, we review currently identified risk factors and pathogenesis of CAM in a pandemic surge.

Keywords: COVID-19; mucormycosis; rhino-orbito-cerebral; steroid therapy; zygomycosis.

PubMed Disclaimer